Understanding how brain development affects risk behavior in adolescents with ADHD
Longitudinal Investigation of the Neurobiological Underpinnings of Risk Behavior in ADHD throughout the Adolescent Transition: The Key Role of Cognitive Control and Motivation Network Development
This study is looking at how the brains of teenagers with ADHD develop and how that affects their choices and behaviors, so we can find better ways to help them make safer decisions.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-10841473 on NIH RePORTER |
What this research studies
This research investigates the neurobiological factors that contribute to risk behaviors in adolescents diagnosed with ADHD. By examining brain development and cognitive control from late childhood to mid-adolescence, the study aims to identify how these factors influence decision-making and behavioral outcomes. Participants will undergo assessments that include brain imaging and behavioral evaluations to track changes over time. The goal is to better understand the connections between brain function and risk-taking behaviors, which can inform more effective interventions.
Who could benefit from this research
Good fit: Ideal candidates for this research are adolescents aged 12 to 20 who have been diagnosed with ADHD.
Not a fit: Patients outside the age range of 12 to 20 or those without a diagnosis of ADHD may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved identification and treatment strategies for adolescents with ADHD, potentially reducing their risk of negative outcomes.
How similar studies have performed: Previous research has shown promising results in understanding the neurobiological underpinnings of ADHD, suggesting that this approach could yield valuable insights.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Cohen, Jessica R — Univ of North Carolina Chapel Hill
- Study coordinator: Cohen, Jessica R
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.